The miRNA silencing of NFKB1 and its differential methylation could therefore be a potential mediator of HCC development; however, further research is needed in order to elucidate the specific role of p50 in different stages of HCC including liver inflammation and disease, and cancer initiation and progression. The gene discussed is NFKB1; the disease is cancer.